Haw ParHAWPF 95 Gross Margin % is 55.32% as of Dec. 2025, which is 2% below its 10-year median of 56.57. GuruFocus rates HAWPF with a GF Score™ of 95/100 and a GF Value™ of $8.79. The stock has 3 warning signs investors should review. Among 938 Drug Manufacturers companies, Haw Par ranks better than 62.79% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Haw Par's Gross Profit for the
six
months ended in Dec. 2025 was $44.4 Mil. Haw Par's Revenue for the
six
months ended in Dec. 2025 was $80.3 Mil. Therefore, Haw Par's Gross Margin % for the quarter that ended in Dec. 2025 was 55.32%.
The historical rank and industry rank for Haw Par's Gross Margin % or its related term are showing as below:
HAWPF'
s Gross Margin % Range Over the Past 10 Years
Min: 43.98 Med: 56.57 Max: 62.73
Current: 55.99
During the past 13 years, the highestGross Margin % of Haw Par was 62.73%. The lowest was 43.98%. And the median was 56.57%.
HAWPF's Gross Margin % is ranked better than 62.79% of 938
companies
in the Drug Manufacturers industry
Industry Median: 48.44
vs HAWPF: 55.99
Haw Par had a gross margin of 55.32% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Haw Par was 4.20% per year.
Haw Par (OTCPK:HAWPF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Haw Par had a gross margin of 55.32% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Haw Par Gross Margin % Related Terms
Haw Par Gross Margin % Historical Data
* Premium members only.
The historical data trend for Haw Par's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HAWPF vs LLY, JNJ, ABBV: Gross Margin % Comparison
For the Drug Manufacturers - General subindustry, Haw Par's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haw Par Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Haw Par's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Haw Par's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Haw Par (HAWPF) has a Gross Margin % of 55.32% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Haw Par and its competitors. This is near median its historical median of 56.57. Over the past decade, Haw Par's Gross Margin % has ranged from 43.98 to 62.73. According to the industry distribution chart, Haw Par ranks #349 out of 938 companies in the Drug Manufacturers industry, placing it in the top 37.2%.
Is Haw Par's Gross Margin % too high?
Haw Par's current Gross Margin % of 55.32% is near median its 10-year median of 56.57. Over the past 10 years, this metric has ranged from a low of 43.98 to a high of 62.73. The Drug Manufacturers industry median Gross Margin % is 48.44. Haw Par's value of 55.32% is 14.2% above this industry median. Based on the distribution chart, Haw Par ranks #349 out of 938 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Haw Par has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Haw Par's Gross Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Haw Par ranks #349 out of 938 companies for Gross Margin %. This puts Haw Par in the upper half of its industry. The industry median Gross Margin % is 48.44. Haw Par's value of 55.32% is 14.2% above this benchmark. Historically, Haw Par's own Gross Margin % has ranged from 43.98 to 62.73 over the past decade. While the company's 10-year median is 56.57 vs. the industry median of 48.44, Haw Par has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.44, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haw Par's current Gross Margin % of 55.32% is 14.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Haw Par and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haw Par's current Gross Margin % is 55.32%, which is near median its own 10-year median of 56.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haw Par stock overvalued right now?
Haw Par (HAWPF) has a current Gross Margin % of 55.32%. The stock's GF Value™ is $8.79, compared to a current price of $12.00 — trading 36.5% above its estimated fair value. The current Gross Margin % is 55.32%, which is near median its 10-year median of 56.57 and 14.2% above the Drug Manufacturers industry median of 48.44. Haw Par's overall GF Score™ is 95/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Haw Par (HAWPF), the current Gross Margin % is 55.32% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Haw Par (HAWPF) Overvalued in 2026?
Based on GuruFocus' analysis, Haw Par stock appears to be overvalued.
The current stock price of $12.00 is trading 36.5% above its estimated GF Value™ of $8.79.
Key valuation signals for HAWPF:
Gross Margin %: 55.32% (near median its 10-year median of 56.57)
GF Value™: $8.79 vs. price of $12.00 (36.5% above fair value)
Industry Position: 14.2% above the Drug Manufacturers median (#349 of 938)
No single metric tells the full story. See the HAWPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, Property segment, and Leisure segment. The company generates the majority of its revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates key revenue from the other ASEAN and other Asian countries.
95GF Score
Get the complete analysis for HAWPF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAWPF has been successfully added to your 
